massachusetts institute of technology today's spotlight about
Close
Spotlight image Spotlight image
The iconic MIT home page Spotlight features a daily-changing image and design that focuses on advances in research, technology and education taking place at the Institute. Though some Spotlights do run multiple days - for example Friday's spot usually runs through the weekend, we work very hard to maintain the daily-changing tradition. We've combed our servers and have compiled a digital archive of the Institute home page through the years - well over 2000 images. Enjoy!
Close
The inside scoopToday’s Spotlight features illustrations by Sam Shun Liang from the MIT Admissions blog.

For the past decade, the MIT Admissions Blogs have been a leader in student blogging. The blogs are written by MIT students and are completely uncensored.

MIT bloggers offer thoughts on anything from something that might interest a prospective student to how to handle the Institute's intense workload to much quirkier topics like how many cats live in dorms at one time or how to set a world record in the game of Mattress Dominos.

Watch the video.
The MIT home page Spotlight showcases the research, technology and education advances taking place at the Institute every day.

What makes it as a Spotlight image is an editorial decision by the MIT News Office based on factors that include timeliness, promotion of MIT's mission, the balance of interest to both internal and external audiences, and appropriateness.

We do welcome ideas and submissions for spotlights from community members, but please note we are not able to accommodate all requests. We are unable to run event previews or promotions as spotlights; for those looking to promote an event, we are happy to include your listing as an event headline on the homepage (when space is available). For more information, e-mail the spotlight team.

Request a Spotlight or Event Headline, here.
Today’s Spotlight is by Christine Daniloff/MIT.

Scientists have known for decades that cancer can be caused by genetic mutations, but more recently they have discovered that chemical modifications of a gene can also contribute to cancer. These alterations, known as epigenetic modifications, control whether a gene is turned on or off. Patients with glioblastoma, a type of brain tumor, respond well to a certain class of drugs known as alkylating agents if the DNA-repair gene MGMT is silenced by epigenetic modification.

A team of MIT chemical engineers has now developed a fast, reliable method to detect this type of modification, known as methylation, which could offer a new way to choose the best treatment for individual patients.


Read full article.